Search for: "D & R Resources, LLC" Results 81 - 100 of 642
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
13 Aug 2020, 1:55 pm by James Kachmar
”  These types of arrangements allow businesses to maximize their complimentary capabilities; ensure stability and supply/demand; and protect R&D and marketing efforts from being exploited by their contractual partners. [read post]
27 Jul 2020, 11:20 am by Renae Lloyd
The company, formerly known as KLR Energy Acquisition Corp., filed a Form D to raise capital from investors in 2017. [read post]
16 Jun 2020, 2:18 pm by Kevin LaCroix
John Reed StarkIs a company’s post-breach forensic report subject to discovery in subsequent breach related litigation? [read post]
The guidelines represent an important intervention into the ongoing debate concerning the tension between standard essential patents (SEPs) (which offer their owners R&D incentives/rewards in the form of monopolistic rights) and technology standards (which should be widely used by all players in the market to ensure interoperability). [read post]
18 May 2020, 4:59 pm by Mitu Gulati
Perhaps the most discussed and hotly debated corporate finance/contracts case of the last year was Windsteam LLC v. [read post]
13 Apr 2020, 4:19 pm by Kevin LaCroix
”[3]   The primary issue presented in the strategic plan for the federal judiciary is: “Scarce resources, changes in litigation and litigant expectations, and certain changes in law challenge the federal judiciary’s effective delivery of justice. [read post]
19 Mar 2020, 10:35 am by Chris Wesner
Along with their petitions, the Debtors filed the declaration of Robert D. [read post]
16 Mar 2020, 1:54 pm by Kevin LaCroix
Apr. 11, 2019), rev’d in part on other grounds, No. 18-CV-2933, 2019 WL 3409684 (S.D.N.Y. [read post]
14 Mar 2020, 11:38 am by Kevin LaCroix
And still others may have gotten to know Perry in recent years in connection with the expert advisory services he provided through his company, Granof International Group, LLC. [read post]
9 Mar 2020, 1:21 pm by Unknown
   · Molly Burich, Director of Public Policy, Boehringer Ingelheim   · Surya Singh, President, Singh Healthcare Advisors, LLC  Moderated Panel Discussion  Meredyth Andrus, Attorney, Health Care Division, Bureau of Competition, FTC Does the designation of interchangeability still have value in the US? [read post]